According to the new market research report “Blood Group Typing Market (Techniques – Microarray, Massively Parallel Sequencing, Assay-based Techniques, and Other Techniques; Test Type – Human Leukocyte Antigen (HLA) Typing, Antibody Screening, ABO Blood Tests, Cross-matching Series, and Antigen Typing; Products Type – Instruments, Services, and Consumables; End User – Clinical Laboratories, Blood Banks, Hospitals, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025” The global Blood Group Typing market was approximately worth USD 2.35 billion in 2018 and is expected to reach over USD 4.5 billion by 2025 with a CAGR of 9.5% during the forecast period from 2019 to 2025.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/13011
Blood group typing enables the medical professional to identify the particular type of the blood of an individual. Blood group typing is depending upon the nature of and the occurrence of antigens in the red blood cells. Blood group typing is the important test that enables to know the similarity of the donor with the receiver, during the blood transfusion or organ donation procedure. Enhancement in the blood detection technique increased the growth of the market.
Rising Number of Road Accident and Trauma and Increasing Number of Blood Test for Blood Transfusion are Contributing to the Growth of the Market
Blood group typing market will expand with a significant rate in the forecast period. Growth of the market is attributed by a significant rise in blood transfusion numbers. The rise in a number of blood cancers such as leukemia, lymphoma, and myeloma and blood-related diseases have increased the number of blood transfusion and organ replacement. Wrong blood group and other blood component selection for the blood transfusion or improper identification of the similarities between donor and acceptor can generate an adverse immune response. The rising number of a road accident and trauma and the increasing number of the blood test for blood transfusion are also contributing to the growth of the market. Moreover, the rising importance of blood group typing during pregnancy is another factor contributing to the growth of the market. Blood group typing is very important thru the time of pregnancy as it aid to prevent extreme anemia in the newborn baby. On the other hand, lack of knowledge and trained experts can hamper the growth of the market. However, continuous demand of blood transfusion in various diseases will provide better opportunities to the market.
Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/13011
Blood group typing market segmented based on techniques, test type, products type and end users. Based on products the blood group typing market is segmented into instruments, services, and consumables. Based on the technique, the market is divided into microarray, massively parallel sequencing, assay-based techniques, and other techniques. Test type bifurcated into human leukocyte antigen (HLA) typing, antibody screening, ABO blood tests, cross-matching series, and antigen typing. Based on the end user, the market can be sub-segmented into clinical laboratories, blood banks, hospitals, and other end users.
Region Wise Performance of “Blood Group Typing Market”
Geographically, blood group typing market is segmented into North America, Europe, Asia-Pacific and Row. North America dominates the market and anticipated to hold the highest share of the market in the forecast period, followed by Europe. Presence of reimbursement policies, rising prevalence of chronic diseases are the factors supporting the growth of the market in this region. The market in Asia Pacific is expected to grow with a high rate in the forecast period. Presence of a large patient pool with blood-related diseases and growing demand for blood transfusion are some of the factor contributing to the growth of the market.
Some of the key players in the market are Quotient Limited, Immucor, Inc., DAY Medical SA, DIAGAST, Novacyt Group, Agena Bioscience, Inc., BAG Health Care GmbH., AXO Science, Ortho Clinical Diagnostics, Inc., Rapid Labs and others.
About Infinium Global Research
Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.
Infinium Global Research
Visit Our Website: https://www.infiniumglobalresearch.com